Cite
Lack of Correlation between CD 52 Expression and Treatment Outcome in PTCL Patients Treated with CHOP Chemotherapy Plus Campath-1h (CHOP-C) as First Line Treatment.
MLA
Gallamini, Andrea, et al. “Lack of Correlation between CD 52 Expression and Treatment Outcome in PTCL Patients Treated with CHOP Chemotherapy Plus Campath-1h (CHOP-C) as First Line Treatment.” Blood, vol. 108, no. 11, Nov. 2006, p. 4732. EBSCOhost, https://doi.org/10.1182/blood.V108.11.4732.4732.
APA
Gallamini, A., Campidelli, C., Zaja, F., Billio, A., Gargantini, L., Manna, A., Secondo, V., Levis, A., Rigacci, L., Mazza, P., Iannitto, E., Pinto, A., Tucci, A., Patti, C., Zoli, V., Torchio, P., Ascani, S., & Pileri, S. (2006). Lack of Correlation between CD 52 Expression and Treatment Outcome in PTCL Patients Treated with CHOP Chemotherapy Plus Campath-1h (CHOP-C) as First Line Treatment. Blood, 108(11), 4732. https://doi.org/10.1182/blood.V108.11.4732.4732
Chicago
Gallamini, Andrea, C. Campidelli, F. Zaja, A. Billio, L. Gargantini, A. Manna, V. Secondo, et al. 2006. “Lack of Correlation between CD 52 Expression and Treatment Outcome in PTCL Patients Treated with CHOP Chemotherapy Plus Campath-1h (CHOP-C) as First Line Treatment.” Blood 108 (11): 4732. doi:10.1182/blood.V108.11.4732.4732.